Table 2 Patient characteristics at... | American Society of Hematology

Table 2

Patient characteristics at transplantation

	CR	nCR	VGPR	PR	SD	PD
Hemoglobin level, g/dL, mean ± SD	11.8 ± 1.5	11.6 ± 1.7	11.3 ± 1.7	11.2 ± 1.7	9.7 ± 1.2	11.1 ± 1.2
Serum creatinine level, μmol/Lm mean ± SD	106 ± 132	88 ± 26	80 ± 26	110 ± 61	102 ± 46	82 ± 21
Serum calcium level, μmol/Lm mean ± SD	232 ± 22	230 ± 20	227 ± 15	227 ± 27	232 ± 12	225 ± 24
Serum albumin level, g/Lm mean ± SD	30 ± 16	29 ± 15	30 ± 15	31 ± 13	30 ± 7	34 ± 7
β₂ microglobulin ≥ 2.5 mg/L, %	29	52	42	43	42	60
LDH > normal limit, %	9	11	6	13	17	35
PS ≥ 2 (ECOG), %	9	21	22	14	41	50
Pre-HDT/SCT different chemotherapy combinations ≥ 2, %	24	36	42	50	62	78
Time from diagnosis to HDT/SCT, mo, mean ± SD	15 ± 22	16 ± 19	16 ± 16	24 ± 31	42	60
Pre-HDT/SCT response status: CR or nCR*/PR/SD/PD, %	23/61/2/14	18/58/6/18	2/72/6/20	0/73/6/21	0/33//37/30	0/42/42/14

	CR	nCR	VGPR	PR	SD	PD
Hemoglobin level, g/dL, mean ± SD	11.8 ± 1.5	11.6 ± 1.7	11.3 ± 1.7	11.2 ± 1.7	9.7 ± 1.2	11.1 ± 1.2
Serum creatinine level, μmol/Lm mean ± SD	106 ± 132	88 ± 26	80 ± 26	110 ± 61	102 ± 46	82 ± 21
Serum calcium level, μmol/Lm mean ± SD	232 ± 22	230 ± 20	227 ± 15	227 ± 27	232 ± 12	225 ± 24
Serum albumin level, g/Lm mean ± SD	30 ± 16	29 ± 15	30 ± 15	31 ± 13	30 ± 7	34 ± 7
β₂ microglobulin ≥ 2.5 mg/L, %	29	52	42	43	42	60
LDH > normal limit, %	9	11	6	13	17	35
PS ≥ 2 (ECOG), %	9	21	22	14	41	50
Pre-HDT/SCT different chemotherapy combinations ≥ 2, %	24	36	42	50	62	78
Time from diagnosis to HDT/SCT, mo, mean ± SD	15 ± 22	16 ± 19	16 ± 16	24 ± 31	42	60
Pre-HDT/SCT response status: CR or nCR*/PR/SD/PD, %	23/61/2/14	18/58/6/18	2/72/6/20	0/73/6/21	0/33//37/30	0/42/42/14

LDH indicates lactate dehydrogenase; PS, performance status; and ECOG, Eastern Cooperative Oncology Group.

Electrophoresis was negative. No immunofixation data were available.